Lifecore Biomedical Sees FY2026 Sales $120.000M-$125.000M vs $129.846M Est

Benzinga Newsdesk www.benzinga.com Positive 73.9%

Neg 0% Neu 0% Pos 73.9%

Lifecore Biomedical (NASDAQ:LFCR) sees FY2026 sales of $120.000 million-$125.000 million vs $129.846 million analyst estimate.